These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

69 related items for PubMed ID: 6987042

  • 21. The role of cephalexin in the treatment of skin and soft-tissue infections.
    Derrick CW, Reilly K.
    Postgrad Med J; 1983; 59 Suppl 5():43-6. PubMed ID: 6364089
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Comparative efficacy and safety of cephradine and cephalexin in children.
    Mouallem R.
    J Int Med Res; 1976; 4(4):265-71. PubMed ID: 799997
    [Abstract] [Full Text] [Related]

  • 24. Effectiveness of cefoperazone in treating cutaneous infections.
    Marley WM, Hester MG, Lober CW, Marlowe SL, Buntin DM, Eaglstein NF, Crutcher N, Rosenberg EW.
    Cutis; 1982 Oct; 30(4):536-7, 541, 547. PubMed ID: 6216074
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Ciprofloxacin: an update on clinical experience.
    Arcieri G, Griffith E, Gruenwaldt G, Heyd A, O'Brien B, Becker N, August R.
    Am J Med; 1987 Apr 27; 82(4A):381-6. PubMed ID: 3555063
    [Abstract] [Full Text] [Related]

  • 27. Telavancin versus vancomycin for the treatment of complicated skin and skin-structure infections caused by gram-positive organisms.
    Stryjewski ME, Graham DR, Wilson SE, O'Riordan W, Young D, Lentnek A, Ross DP, Fowler VG, Hopkins A, Friedland HD, Barriere SL, Kitt MM, Corey GR, Assessment of Telavancin in Complicated Skin and Skin-Structure Infections Study.
    Clin Infect Dis; 2008 Jun 01; 46(11):1683-93. PubMed ID: 18444791
    [Abstract] [Full Text] [Related]

  • 28. "Discontinuous" antibiotic therapy for urinary tract infections.
    Caloza DL, Fields LA, Bernfeld GE.
    Scand J Infect Dis; 1978 Jun 01; 10(1):75-8. PubMed ID: 345423
    [Abstract] [Full Text] [Related]

  • 29. [Linezolid in the treatment of antibiotic-resistant gram-positive infections of the musculoskeletal system].
    Jahoda D, Nyc O, Pokorný D, Landor I, Sosna A.
    Acta Chir Orthop Traumatol Cech; 2006 Oct 01; 73(5):329-33. PubMed ID: 17140514
    [Abstract] [Full Text] [Related]

  • 30. Telavancin versus vancomycin for the treatment of complicated skin and skin-structure infections associated with surgical procedures.
    Wilson SE, O'Riordan W, Hopkins A, Friedland HD, Barriere SL, Kitt MM, ATLAS Investigators.
    Am J Surg; 2009 Jun 01; 197(6):791-6. PubMed ID: 19095213
    [Abstract] [Full Text] [Related]

  • 31. Clinical profile of ceftobiprole, a novel beta-lactam antibiotic.
    Noel GJ.
    Clin Microbiol Infect; 2007 Jun 01; 13 Suppl 2():25-9. PubMed ID: 17488373
    [Abstract] [Full Text] [Related]

  • 32. A comparative evaluation of oral ofloxacin versus intravenous cefotaxime therapy for serious skin and skin structure infections.
    Gentry LO, Rodriguez-Gomez G, Zeluff BJ, Khoshdel A, Price M.
    Am J Med; 1989 Dec 29; 87(6C):57S-60S. PubMed ID: 2690621
    [Abstract] [Full Text] [Related]

  • 33. Cefdinir vs. cephalexin for mild to moderate uncomplicated skin and skin structure infections in adolescents and adults.
    Giordano PA, Elston D, Akinlade BK, Weber K, Notario GF, Busman TA, Cifaldi M, Nilius AM.
    Curr Med Res Opin; 2006 Dec 29; 22(12):2419-28. PubMed ID: 17257456
    [Abstract] [Full Text] [Related]

  • 34. Systemic antibiotic treatment of skin, skin structure, and soft tissue infections in the outpatient setting.
    Jones H.
    Adv Skin Wound Care; 2012 Mar 29; 25(3):132-40; quiz 141-2. PubMed ID: 22343601
    [Abstract] [Full Text] [Related]

  • 35. Cefdinir: an oral cephalosporin for the treatment of respiratory tract infections and skin and skin structure infections.
    Sader HS, Jones RN.
    Expert Rev Anti Infect Ther; 2007 Feb 29; 5(1):29-43. PubMed ID: 17266451
    [Abstract] [Full Text] [Related]

  • 36. Staphylococcus aureus nasal carriage and infection in patients on hemodialysis. Efficacy of antibiotic prophylaxis.
    Yu VL, Goetz A, Wagener M, Smith PB, Rihs JD, Hanchett J, Zuravleff JJ.
    N Engl J Med; 1986 Jul 10; 315(2):91-6. PubMed ID: 3523240
    [Abstract] [Full Text] [Related]

  • 37. Cost-effectiveness of linezolid versus vancomycin for hospitalized patients with complicated skin and soft-tissue infections in France.
    De Cock E, Sorensen S, Levrat F, Besnier JM, Dupon M, Guery B, Duttagupta S.
    Med Mal Infect; 2009 May 10; 39(5):330-40. PubMed ID: 19304423
    [Abstract] [Full Text] [Related]

  • 38. Daptomycin versus vancomycin for complicated skin and skin structure infections: clinical and economic outcomes.
    Davis SL, McKinnon PS, Hall LM, Delgado G, Rose W, Wilson RF, Rybak MJ.
    Pharmacotherapy; 2007 Dec 10; 27(12):1611-8. PubMed ID: 18041881
    [Abstract] [Full Text] [Related]

  • 39. CANVAS 1: the first Phase III, randomized, double-blind study evaluating ceftaroline fosamil for the treatment of patients with complicated skin and skin structure infections.
    Corey GR, Wilcox MH, Talbot GH, Thye D, Friedland D, Baculik T, CANVAS 1 investigators.
    J Antimicrob Chemother; 2010 Nov 10; 65 Suppl 4():iv41-51. PubMed ID: 21115454
    [Abstract] [Full Text] [Related]

  • 40. [Efficacy and tolerability of cefazedone in infectious skin diseases; determination of serum and tissue concentrations (author's transl)].
    Schneider C, Koch E.
    Derm Beruf Umwelt; 1979 Nov 10; 27(3):75-7. PubMed ID: 487944
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 4.